Mizuho cuts Cava Group target price to $56 from $70
CAVA•Mizuho cut its target price for Cava Group to $56 from $70.
Related News
NRx Pharmaceuticals receives FDA approval of preservative-free ketamine ahead of November 10 goal date
NRXP•
Genworth Financial announces leadership transition
GNW•
Reddit, Pinterest shares tumble on weak user and revenue growth
PINS•
Robinhood Markets: Truist Securities cuts target price to $123 from $125
HOOD•
Valion Bio advances Entolimod to US-funded radiation survival study
VBIO•